Radnet, INC

RadNet, Inc. has entered into an incremental amendment to its credit agreement, securing $250 million in new term loans while reducing interest rates on its credit facilities by 0.25%.

RadNet, Inc. announced its intention to secure a $200 million incremental term loan to fund strategic growth opportunities including acquisitions and expansion.

RadNet announced record first-quarter 2026 financial results, exceeding prior year performance and leading to upward revisions in full-year guidance for revenue, Adjusted EBITDA, and Free Cash Flow.

RadNet, Inc. reported record fourth-quarter 2025 revenue and Adjusted EBITDA, driven by strong procedural growth and strategic AI investments, while issuing robust 2026 financial guidance.

RadNet's DeepHealth subsidiary acquired French AI radiology firm Gleamer for up to €230 million, creating the world's largest provider of clinical AI solutions.

RadNet, Inc. filed a prospectus supplement to register 190,924 common shares for resale by sellers involved in its November 2025 acquisition of Cimar (UK) Limited.

RadNet reports a significant increase in total service revenue for Q1 2026, driven by its Imaging Centers segment, but a wider net loss attributable to increased operating expenses and strategic acquisitions.

RadNet reports strong third-quarter revenue growth driven by strategic acquisitions and increased advanced imaging procedures, despite widening year-to-date net losses.

RadNet, a leading diagnostic imaging provider, reported a return to profitability in Q2 2025 with strong revenue growth, though its six-month net loss widened due to strategic investments and increased operating costs.

RadNet's Q1 2025 shows revenue growth driven by imaging services and digital health, but a net loss due to increased operating expenses and strategic investments.

RadNet, Inc. announced its Q3 2024 financial results, showing revenue growth driven by acquisitions and increased procedure volumes, but also a net loss attributable to common stockholders.

RadNet's Q2 2024 results show revenue growth driven by increased procedure volumes and strategic acquisitions, alongside a refinancing of their credit facility.

RadNet's 2025 annual report reveals significant revenue growth driven by imaging center expansion and AI investments, alongside executive compensation increases and a net loss for common stockholders.

RadNet, Inc. amends its original Form 10-K filing to include the Insider Trading Policy, which was inadvertently omitted.

RadNet's 2024 annual report highlights revenue growth driven by imaging center acquisitions and organic expansion, alongside strategic investments in digital health and artificial intelligence.

RadNet's 10-K filing reveals a year of growth driven by increased procedure volumes and strategic acquisitions, alongside investments in artificial intelligence and technology.

Cornelis Wesdorp, President & CEO of Digital Health at RadNet, Inc., reported a sale of 4,750 shares of common stock.

Howard G. Berger, President and CEO of RadNet, Inc., reported a transaction involving the gift of 90 shares of common stock by his spouse.

RadNet, Inc. executive Stephen M. Forthuber reported the sale of a significant number of company shares, totaling over $2.3 million, on June 15, 2026.

Director David Swartz acquired 2,946 shares of RadNet, Inc. common stock as part of a routine equity grant.

RadNet, Inc. Director Gregory E. Spurlock acquired 2,946 shares of common stock on June 2, 2026.

RadNet, Inc. Director Laura Pastre Jacobs acquired 2,946 shares of common stock as part of a routine equity grant.

RadNet, Inc. has filed its 2026 Proxy Statement, seeking stockholder approval for director elections, auditor ratification, executive compensation, and an amendment to its Equity Incentive Plan.

RadNet, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

RadNet, Inc. is set to hold its 2025 Annual Meeting of Stockholders on June 10, 2025, to vote on director elections, auditor ratification, executive compensation, and other business matters.

RadNet, Inc. announces its 2024 Annual Meeting of Stockholders to be held on June 12, 2024, and provides information on how stockholders can access proxy materials and vote.

RadNet, Inc. has scheduled its 2024 Annual Meeting of Stockholders for June 12, 2024, to address director elections, auditor ratification, executive compensation, and other business matters.

T. Rowe Price Associates, Inc. has reported beneficial ownership of 5.4% of RadNet Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 3,952,160 shares of RadNet Inc. common stock, representing 5.09% of the class.

The Vanguard Group has reported zero beneficial ownership in RadNet Inc. common stock following an internal realignment that disaggregated reporting responsibilities.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 5.1% beneficial ownership stake in RadNet, Inc. common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 12.0% beneficial ownership in RadNet, Inc. common stock as of September 30, 2025.

The Vanguard Group has filed an amended Schedule 13G, reporting a 10.03% passive beneficial ownership stake in RadNet Inc. as of December 31, 2024.